Brighton Jones’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-33,271
Closed -$89.8K – 1432
2026
Q2
$89.8K Buy
33,271
+18,834
+130% +$34.9K ﹤0.01% 1320
2026
Q1
$17.3K Buy
+14,437
New +$17.6K ﹤0.01% 1190

Other funds holding FATE

Brighton Jones's FATE Position: Q3 2026 in Review

Brighton Jones sold out of Fate Therapeutics (FATE) in Q3 2026, closing a stake of 33,271 shares — an estimated $89.8K sold.

Brighton Jones first reported a position in FATE in Q1 2026 and held it in 2 quarters. The position peaked at $89.8K in Q2 2026. 117 funds tracked by Wall St. Rank hold FATE as of Q3 2026.

  • Brighton Jones reported no remaining Fate Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Brighton Jones sold 33,271 Fate Therapeutics shares in Q3 2026, an estimated $89.8K.
  • Brighton Jones first reported a position in Fate Therapeutics in Q1 2026 and held it in 2 quarters.
  • Brighton Jones's Fate Therapeutics position peaked at $89.8K in Q2 2026.
  • 117 funds tracked by Wall St. Rank held Fate Therapeutics as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.